Maxcyte (MXCT) Interest & Investment Income (2020 - 2026)

Maxcyte (MXCT) has 7 years of Interest & Investment Income data on file, last reported at $1.4 million in Q1 2026.

• On a quarterly basis, Interest & Investment Income fell 29.45% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $6.7 million, a 29.27% decrease from a year earlier, with the FY2025 full-year figure at $7.3 million, down 28.35% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $1.4 million, down from $1.6 million in the prior quarter.
• Over the last five years, Interest & Investment Income for MXCT reached as high as $2.8 million in Q4 2023 and fell as low as $91800.0 in Q1 2022.
• Historically, Interest & Investment Income has averaged $1.9 million across 5 years, with a median of $2.0 million in 2025.
• Across the five-year window, Interest & Investment Income soared 5466.28% in 2022 and tumbled 30.57% in 2025, its largest moves.
• Year by year, Interest & Investment Income stood at $2.0 million in 2022, then soared by 44.36% to $2.8 million in 2023, then decreased by 18.24% to $2.3 million in 2024, then fell by 29.25% to $1.6 million in 2025, then slipped by 11.96% to $1.4 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $1.4 million in Q1 2026, $1.6 million in Q4 2025, and $1.7 million in Q3 2025.